Alyssa Clay

Population-Based Analysis of Hematologic Malignancy Referrals to a Comprehensive Cancer Center, Referrals for Blood and Marrow Transplantation, and Participation in Clinical Trial, Survey, and Biospecimen Research by Race.

K. Moysich, P. McCarthy, T. Hahn, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

Lara E Sucheston-Campbell, A. Whittemore, M. Beckmann, 2016, Cancer Epidemiology, Biomarkers & Prevention.

Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime?

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, Qianqian Zhu, 2015, Current Hematologic Malignancy Reports.

Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, D. Tritchler, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

Yurii B. Shvetsov, Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, 2016, Oncotarget.